For instance, Zhao et al. (2015) developed a nanoparticle-based drug delivery system that specifically targets GRP78-expressing cancer cells, resulting in improved drug efficacy and reduced systemic toxicity (Zhao et al. 2015). This evidence concerns the gene HSPA5 and cancer.